I see PainChek as an evolutionary development of my past work, incorporating new technologies including smart devices and artificial intelligence that further improves the pain assessment process. There are many people who still do not have their pain assessed effectively. Our common goal is to ensure they do not suffer unnecessary pain” Dr Abbey commented.
What an asset to the team...
Ann: Dr Jennifer Abbey joins PainChek Ltd clinical advisory board, page-10
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.61M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90865 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 200123 | 2 |
View Market Depth
| Last trade - 09.48am 12/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable